Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1085-1089

  Tsunoda, T ^a   Tanimura, H ^a   Yamaue, H ^a   Iwahashi, M ^a   Tani, M ^a   Noguchi, K ^a   Hotta, T ^a   Mizobata, S ^a   Arii, K ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 4; Interleukin 2 receptor; Scathard analysis; Tumour infiltrating lymphocyte

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; INTERNALIZATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0029785966     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.494     Document Type: Article

References (39)

1. BLUE M, DALEY FJ, LEVINE H AND SCHLOSSMAN ES. (1985). Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J. Immunol., 134, 2281-2286.
2. EBERT CE, BROLIN ER AND ROBERTS IA. (1989). Characterization of activated lymphocytes in colon cancer. Clin. Immunol. Immunopathol., 50, 72-81.
3. FERNANDEZ-BOTRAN R, SANDERS VM AND VITETTA ES. (1989). Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL 1). J. Exp. Med., 169, 379-391.
4. FUJII M, SUGAMURA K, SANO K, NAKAI M, SUGITA K AND HIMURA Y. (1986). High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J. Exp. Med., 163, 550-562.
5. HOROHOV DW, CRIM JA, SMITH PL AND SIEGEL JP. (1988). IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol., 141, 4117-4223.
6. HOWARD M, FARRAR J, HILFIKER M, JOHNSON B, TAKATSU K, HAMAOKA T AND PAUL WE. (1982). Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med., 155, 914-923.
7. ISHIKAWA T, UCHIYAMA T, KAMIO M, ONISHI R, KODAKA T AND OKUMA M. (1991). IL-4 down-regulates IL-2 receptor p75 by accelerating its endocytosis. Int. Immunol., 3, 517-525.
8. IWAHASHI M, TANIMURA H, YAMAUE H, TSUNODA T, TANI M, NOGUCHI K, MIZOBATA S, HOTTA T AND TAMAI M. (1993). An autoreactive T cell clone generated in the autologous mixed lymphocytes reaction in a patient with gastric carcinoma. J. Clin. Lab. Immunol., 40, 29-37.
9. KAWAKAMI Y, ROSENBERG SA AND LOTZE MT. (1988). Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med., 168, 2183-2191.
10. KAWAKAMI Y, CUSTER MC, ROSENBERG SA AND LOTZE TM (1989). IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol., 142, 3452-3461.
11. KAWAKAMI Y, HAAS GP AND LOTZE MT. (1993). Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4. J. Immunother., 14, 336-347.
12. KONDO M, TAKESHITA T, ISHII N, NAKAMURA M, WATANABE S, ARAI K AND SUGAMURA K. (1993). Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science, 262, 1874-1877.
13. LORRE K, DAMME VJ AND CEUPPENS LJ. (1990). A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation. Eur. J. Immunol., 20, 1569-1575.
14. MCPHEE D, PYE J AND SHORTMAN K. (1979). The differentiation of T lymphocytes. Evidence for intrathymic death of most thymocytes. Thymus, 1, 151-162.
15. MITCHELL LC, DAVIS LS AND LIPSKY PE. (1989). Promotion of human T lymphocyte proliferation by IL-4. J. Immunol., 142, 1548-1557.
16. MOSMANN TR, CHERWINSKI H, BOND MW, GIEDLIN MA AND COFFMAN RL. (1986). Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136, 2348-2357.
17. MULE JJ, SMITH CA AND ROSENBERG SA. (1987). Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J. Exp. Med., 166, 792-797.
18. NAGLER A, LANIER LL AND PHILLIPS JH. (1988). The effect of IL-4 on human natural killer cells. A potent regulator of IL-2-activation and proliferation. J. Immunol., 142, 2349-2351.
19. NAKAMURA M, ASAO H, TAKESHITA T AND SUGAMURA K. (1993). Interleukin-2 receptor heterotrimer complex and intracellular signaling. Semin. Immunol., 5, 309-317.
20. + T-cell clones. Nature, 335, 642-644.
21. PAUL WE AND OHARA J. (1987). B-cell stimulatory factor-1/ interleukin-4. Annu. Rev. Immunol., 5, 429-459.
22. PENIT C. (1986). In vitro thymocyte maturation. BUdR labeling of cycling thymocytes and phenotypic analysis of their progeny support the single lineage model. J. Immunol., 137, 2115-2121.
23. ROBB JR AND GREEN CW. (1987). Internalization of interleukin 2 is mediated by the β chain of the high-affinity interleukin 2 receptor. J. Exp. Med., 165, 1201-1206.
24. ROBB JR, GREEN CW AND RUSK MC. (1984). Low and high affinity cellular receptors for interleukin 2. J. Exp. Med., 160, 1126-1146.
25. ROSENBERG SA, SEPIESS P AND LATRENIERE R. (1986). A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science, 233, 1318-1321.
26. SHIMIZU Y, IWATSUKI S, HERBERMAN BR AND WHITESIDE LT. (1990). Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int. J. Cancer, 46, 878-883.
27. SIEGEL JP, MICHAEL S, SMITH PL AND LEONARD WJ. (1987). The IL-2 receptor β chain (p70): role in mediating signals for LAK. NK, and proliferative activities. Science. 238, 75-78.
28. SPITS H, YSSEL H AND TAKEBE T. (1987). Recombinant interleukin-4 promotes the growth of human T cells. J. Immunol., 139, 1142-1147.
29. SWAIN SL, MCKENZIE DT, DUTTON RW, TONKONOGY SL AND ENGLISH M. (1988). The role of IL-4 and IL-5: characterization of a distinct helper T cell subset that makes IL-4 and IL-5 (Th2) and requires priming before induction lymphokine secretion. Immunol. Rev., 102, 77-105.
30. TAKESHITA T, ASAO H, OHTANI K, ISHII N, KUMAKI S, TANAKA N, NAKAMURA M AND SUGAMURA K. (1992). Cloning of the gamma chain of the human IL-2 receptor. Science, 257, 379-382.
31. TOPALIAN SL, SOLOMON D, AVIS FP, CHANG AE, FREEEKSEN DL, MARSTON LINEHAN W, LOTZE MT, ROBERTSON CN, SEIPP CA, SIMON P, SIMPSON CG AND ROSENBERG SA. (1988). Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin 2: a pilot study. J. Clin. Oncol., 6, 839-853.
32. TSUNODA T, TANIMURA H, YAMAUE H, IWAHASHI M, TANI M, TAMAI M, ARII K AND NOGUCHI K. (1992a). The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor. Biotherapy, 4, 9-15.
33. TSUNODA T, TANIMURA H, YAMAUE H, IWAHASHI M, TANI M, TAMAI M, ARII K AND NOGUCHI K. (1992b). In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients. Int. J. Immunopharmacol., 14, 75-81.
34. VIALE M, FERRIN S, SERRANO S, ARDIZZONI A AND NICOLIN A. (1990). Peripheral blood and tumor-infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level, Tumori, 76, 484-488.
35. WHITESIDE LT, MIESCHER S, MORETTA L AND FLIEDNER V. (1986). Clonal analysis and in situ characterization of human breast carcinomas. Cancer Immunol. Immunother., 23, 169-178.
36. WHITFORD P, MALLON AE, GEORGE DW AND CAMPBELL M. (1990). Flow cytometric analysis of tumour-infiltrating lymphocytes in breast cancer. Br. J. Cancer, 62, 971-975.
37. YAGITA H, NAKATA M, AZUMA A, NITTA T, TAKESHITA T, SUGAMURA K AND OKUMURA K. (1989). Activation of peripheral blood T cells via the p75 interleukin 2 receptor. J Exp. Med., 170, 1445-1450.
38. YAMAUE H, TANIMURA H, TSUNODA T, IWAHASHI M, TANI M, TAMAI M, AND INOUE M. (1990). Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes. Biotherapy, 2, 247-259.
39. YOSHIMOTO T, NAKANISHI K, MATSUI K, HIROSE S, HIROISHI K, TANAKA T, HADA T, HAMAOKA T AND HIGASHIO K. (1990). IL-5 up-regulates but IL-4 down-regulates IL-2 R expression on a cloned B lymphoma line. J. Immunol., 144, 183-190.